VF
EVFM

Virtu Financial’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Virtu Financial’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,338
Closed -$98K – 2445
2021
Q4 		$98K Buy
17,338
+15,269
+738% +$130K 0.01% 1141
2021
Q3 		$23K Sell
2,069
-8,548
-81% -$107K ﹤0.01% 1375
2021
Q2 		$180K Sell
10,617
-1,013
-9% -$19.2K 0.02% 1041
2021
Q1 		$305K Buy
11,630
+10,921
+1,540% +$496K 0.02% 811
2020
Q4 		$26K Buy
+709
New +$25.6K ﹤0.01% 1335

Other funds holding EVFM

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's EVFM Position: Q1 2022 in Review

Virtu Financial sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q1 2022, closing a stake of 17,338 shares — an estimated $98K sold.

Virtu Financial first reported a position in EVFM in Q4 2020 and held it in 5 quarters. The position peaked at $305K in Q1 2021. 68 funds tracked by Wall St. Rank hold EVFM as of Q1 2022.

  • Virtu Financial reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Virtu Financial sold 17,338 Evofem Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $98K.
  • Virtu Financial first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Virtu Financial's Evofem Biosciences, Inc. Common Stock position peaked at $305K in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q1 2022.

Based on Virtu Financial's 13F filing for Q1 2022, filed 17 May 2022.